EP-104GI Performs Well in Eosinophilic Esophagitis (EoE) Trial
The Phase 1b/2a RESOLVE clinical study set out to identify how safe and effective EP-104GI is for people living with a chronic immune-mediated disease called eosinophilic esophagitis (EoE). People with…